Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort.
G S AlarcónManuel Francisco Ugarte-GilG Pons-EstelL M ViláJ D ReveilleG McGwinPublished in: Lupus (2019)
The longer the patient's state on Remission/LDAS, the less damage accrual that occurs. The protective effect on mortality was not statistically significant.
Keyphrases
- disease activity
- systemic lupus erythematosus
- rheumatoid arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- end stage renal disease
- juvenile idiopathic arthritis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- oxidative stress
- prognostic factors
- cardiovascular events
- case report
- cardiovascular disease
- ulcerative colitis
- type diabetes
- clinical trial